Brainvectis

Recent Finacing

Series A

Recent Raise

$1.1M

BrainVectis is a France-based biotech developing CYP46A1-targeted gene therapies to restore brain cholesterol metabolism for treating Huntington’s disease and Alzheimer’s disease.

Founded 2015

Ile-de-France, France

1-10

Private

brainvectis.com

Highlights

Focus Areas

Medical

Medical Device

Therapeutics

Financials

$1.1M

Total Raised

1

Funding round